Internal Medicine, Hematology & Oncology · Pittsburgh, PA
NPI
1750607404
Since 2010
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4815 Liberty Ave Ste 322
Pittsburgh, PA, 15224
Phone (412) 578-4484
Groups this clinician bills Medicare through
Medicare paid, 2024
$64K
702 services
Medicare patients, 2024
143
Average age 72
Drug cost, 2024
$3.5M
1,037 prescriptions
Company payments, 2025
$5,351
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anna Koget was code 99233 (hospital e&m - subsequent), 376 times for 71 patients. In total Anna Koget billed 702 services in 18 codes, and Medicare paid $64K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 376 | 71 | $90.73 | $34K |
| 99214 Office E&M - Established | Office | 207 | 72 | $89.76 | $19K |
| 99239 Hospital Discharge Management | Facility | 31 | 28 | $89.18 | $2,765 |
| 99223 Hospital E&M - Initial | Facility | 26 | 20 | $135.82 | $3,531 |
By year: 2022 $57K for 706 services; 2023 $64K for 727 services; 2024 $64K for 702 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anna Koget prescribed most often to Medicare patients was Acyclovir, with 225 prescriptions and refills. In total Anna Koget wrote 1,037 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 225 | 257 | 43 | $2,438 |
| Venclexta Venetoclax | 61 | 62 | 17 | $107K |
| Hydroxyurea Generic | 55 | 67 | 11 | $860 |
| Allopurinol Generic | 55 | 67 | 13 | $234 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 49 | 51 | 13 | $56.33 |
| Sprycel Dasatinib | 45 | 45 | Under 11 | $734K |
| Voriconazole Generic | 39 | 39 | Under 11 | $13K |
| Ciprofloxacin Hcl Generic | 32 | 39 | 15 | $425 |
| Ondansetron Hcl Generic | 30 | 40 | 17 | $89.46 |
| Eliquis Apixaban | 27 | 27 | Under 11 | $15K |
| Fluconazole Generic | 26 | 31 | 12 | $2,315 |
| Potassium Chloride Generic | 26 | 30 | Under 11 | $820 |
| Prochlorperazine Maleate Generic | 25 | 25 | 20 | $279 |
| Famotidine Generic | 22 | 30 | Under 11 | $65.82 |
| Imatinib Mesylate Generic | 21 | 21 | Under 11 | $77K |
Brand drugs: 243 claims; generic drugs: 794 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anna Koget $5,351 ($5,351 in general payments such as food, travel and fees) from 7 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $4,260.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.